Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL17353587 | 0.98 | CHRNA7 (0.55) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| Hydrochloric Acid SCHEMBL28122048 | 0.98 | CHRNA7 (0.55) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL11329185 | 0.89 | CYP2A6 (0.59) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL8199625 | 0.87 | TDP1 (0.61) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL2050612 | 0.83 | — | — | |
| SCHEMBL724866 | 0.80 | CHRNA7 (0.74) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL29485692 | 0.80 | CHRNA7 (0.74) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL2690999 | 0.80 | CHRNA7 (0.45) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL10888485 | 0.80 | CHRNA7 (0.57) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL348856 | 0.80 | CHRNA7 (0.57) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998033776-A1 | COMBINATORIAL LIBRARIES OF HYDANTOIN AND THIOHYDANTOIN DERIVATIVES, METHODS OF MAKING THE LIBRARIES AND COMPOUNDS THEREIN | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| US-5550233-A | AUTOIMMUNE DISEASES; PREVENTION OF TRANSPLANT REJECTION | MERCK & CO., INC. (US) | 1996-08-27 | — | — | US | claimed |
| US-5252732-A | D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity | MERCK & CO., INC. (US) | 1993-10-12 | — | — | US | claimed |
| US-20240335490-A1 | COMPOSITION FOR PREVENTING OR AMELIORATING LOCOMOTIVE SYNDROME | DIC CORPORATION (JP) | 2024-10-10 | — | — | US | disclosed |
| US-8993773-B2 | Process to prepare pioglitazone via several novel intermediates | CADILA HEALTHCARE LIMITED (IN) | 2015-03-31 | — | — | US | disclosed |
| US-20140088127-A1 | NOVEL PROCESS TO PREPARE PIOGLITAZONE VIA SEVERAL NOVEL INTERMEDIATES | CADILA HEALTHCARE LIMITED (IN) | 2014-03-27 | — | — | US | disclosed |
| US-8445685-B2 | Process to prepare pioglitazone via several novel intermediates | CADILA HEALTHCARE LIMITED (IN) | 2013-05-21 | — | — | US | disclosed |
| US-8173816-B2 | Process to prepare pioglitazone via several novel intermediates | CADILA HEALTHCARE LIMITED (IN) | 2012-05-08 | — | — | US | disclosed |
| US-20120077848-A1 | NOVEL PROCESS TO PREPARE PIOGLITAZONE VIA SEVERAL NOVEL INTERMEDIATES | CADILA HEALTHCARE LIMITED (IN) | 2012-03-29 | — | — | US | disclosed |
| US-20120041019-A1 | PROTEASE INHIBITORS | AMPLYX PHARMACEUTICALS, INC. | 2012-02-16 | — | — | US | disclosed |
| US-20120041019-A1 | PROTEASE INHIBITORS | AMPLYX PHARMACEUTICALS, INC. | 2012-02-16 | — | — | US | disclosed |
| US-4146489-A | LUBRICANTS, DISPERSANTS | ROHM AND HAAS COMPANY (US) | 1979-03-27 | — | — | US | disclosed |
| US-4117240-A | CONTAINING ANTIOXIDANT PHENOLIC DERIVATIVES OF ACRYLIC ESTERS AS MONOMERS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4087619-A | Amine containing antioxidants | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4021404-A | AMIDES, NATURAL AND SYNTHETIC RUBBERS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
| US-3979436-A | ACRYLIC ESTERS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3962187-A | STABILIZED POLYMERS OF DITERTIARY ALKYL-4-HYDROXYBENZYLOXY ALKYL ACRYLATES AND DIENES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3953411-A | Age resistant polymers of 4-(arylamino)aryl esters of α,β unsaturated carboxylic acids | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3953402-A | COPOLYMER OF A P-HYDROXYPHENYL ACRYLATE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3953398-A | 3,5-DI-TERT-ALKYL-4-HYDROXYCINNAMIC ACID OR ESTER AS STABILIZER | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140088127-A1 | NOVEL PROCESS TO PREPARE PIOGLITAZONE VIA SEVERAL NOVEL INTERMEDIATES | PPARD, PPARG, PPARA | CHRNA7 4218/4885CYP2A6 203/4885TDP1 3723/4885 |
| US-20120077848-A1 | NOVEL PROCESS TO PREPARE PIOGLITAZONE VIA SEVERAL NOVEL INTERMEDIATES | PPARD, PPARG, PPARA | CHRNA7 4218/4885CYP2A6 203/4885TDP1 3723/4885 |
| US-20120041019-A1 | PROTEASE INHIBITORS | SERPINB1, PREP, DNPEP | CHRNA7 4874/4885CYP2A6 2737/4885TDP1 1008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.